The Penetratin Sequence in the Anticancer PNC-28 Peptide Causes Tumor Cell Necrosis Rather Than Apoptosis of Human Pancreatic Cancer Cells
Authors:
- 18 October 2008
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 15 (12) , 3588-3600
Abstract
PNC-27 and PNC-28 are p53-derived peptides from the human double minute (hdm-2) binding domain attached to penetratin. These peptides induce tumor cell necrosis of cancer cells, but not normal cells. The anticancer activity and mechanism of PNC-28 (p53 aa17–26-penetratin) was specifically studied against human pancreatic cancer. MiaPaCa-2 cells were treated with PNC-28. Necrosis was determined by measuring lactate dehydrogenase (LDH) and apoptosis as assayed for measuring elevation of proapoptotic proteins. PNC-29, an unrelated peptide, and hdm-2-binding domain p53 aa12-26 without penetratin (PNC-26) were used as controls. Since there is evidence that penetratin is required for tumor cell necrosis, we tested “naked” p53 peptide without penetratin by transfecting a plasmid that encodes p53 aa17–26 segment of PNC-28 into MiaPaCa-2 and an untransformed rat pancreatic acinar cell line, BMRPA1. Time-lapse electron microscopy was employed to further elucidate anticancer mechanism. Treatment with PNC-28 does not result in the elevation of proapoptotic proteins found in p53-induced apoptosis, but elicits rapid release of LDH, indicative of tumor cell necrosis. Accordingly, we observed membrane pore formation and dose-dependent killing. In direct contrast, transfected MiaPaCa-2 cells underwent apoptosis, and not necrosis, as evidenced by expression of high levels of caspases-3 and 7 and annexin V with background levels of LDH. These results suggest that PNC-28 may be effective in treating human pancreatic cancer. The penetratin sequence appears to be responsible for the fundamental change in the mechanism of action, inducing rapid necrosis initiated by membrane pore formation. Cancer cell death by apoptosis was observed in the absence of penetratin.Keywords
This publication has 13 references indexed in Scilit:
- PNC‐28, a p53‐derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivoInternational Journal of Cancer, 2006
- The role of alpha-helical structure in p53 peptides as a determinant for their mechanism of cell death: necrosis versus apoptosisAdvanced Drug Delivery Reviews, 2005
- NMR Solution Structure of a Peptide from the mdm-2 Binding Domain of the p53 Protein that Is Selectively Cytotoxic to Cancer Cells,Biochemistry, 2004
- Peptides designed from molecular modeling studies of the ras -p21 protein induce phenotypic reversion of a pancreatic carcinoma cell line but have no effect on normal pancreatic acinar cell growthCancer Chemotherapy and Pharmacology, 2003
- Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding siteOncogene, 2003
- Study of the cytotoxic effect of a peptidic inhibitor of the p53–hdm2 interaction in tumor cellsFEBS Letters, 2002
- Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cellsProceedings of the National Academy of Sciences, 2001
- Coupling of the antennapedia third helix to a potent antagonist of the p53/hdm2 protein–protein interactionBioorganic & Medicinal Chemistry Letters, 2001
- p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53Oncogene, 1999
- Cell surface exposure of phosphatidylserine during apoptosis is phylogenetically conservedApoptosis, 1998